INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
CE

Claypoole Robert E

Director, President and CEOCIK 0002005474

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 0
Max Insider Score27
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
CE
Claypoole Robert EDirector, President and CEO
BVSBioventus Inc.
Option exercise
M—
33.5K sh
Mar 13, 2026Mar 17, 2026
traded Mar 13, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Bioventus Inc.Director, President and CEO · Jan 13, 2026
24
CE
Claypoole Robert EDirector, President and CEO
BVSBioventus Inc.
Grant or award
A
—
153.0K sh
Mar 14, 2025
Mar 17, 2026
traded Mar 14, 2025
+368d
SEC FORM 4

Evidence

9
CE
Claypoole Robert EDirector, President and CEO
BVSBioventus Inc.
Grant or award
A—
278.0K sh
Mar 13, 2026Mar 17, 2026
traded Mar 13, 2026
+4dSEC FORM 4

Evidence

9
CE
Claypoole Robert EDirector, President and CEO
BVSBioventus Inc.
Grant or award
A—
309.0K sh
Mar 13, 2026Mar 17, 2026
traded Mar 13, 2026
+4dSEC FORM 4

Evidence

17
CE
Claypoole Robert EDirector, President and CEO
BVSBioventus Inc.
Option exercise
M—
33.5K sh
Mar 13, 2026Mar 17, 2026
traded Mar 13, 2026
+4dSEC FORM 4

Evidence

16
CE
Claypoole Robert EDirector, President and CEO
BVSBioventus Inc.
Tax withholding
F$125K
14.6K sh
Mar 13, 2026Mar 17, 2026
traded Mar 13, 2026
+4dSEC FORM 4

Evidence

24
CE
Claypoole Robert EDirector, President and CEO
BVSBioventus Inc.
Grant or award
A—
134.0K sh
Mar 14, 2025Mar 17, 2026
traded Mar 14, 2025
+368dSEC FORM 4

Evidence

27
CE
Claypoole Robert EDirector, President and CEO
BVSBioventus Inc.
Tax withholding
F$335K
41.7K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC FORM 4

Evidence

21
CE
Claypoole Robert EDirector, President and CEO
BVSBioventus Inc.
Option exercise
M—
93.8K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC FORM 4

Evidence

21
CE
Claypoole Robert EDirector, President and CEO
BVSBioventus Inc.
Option exercise
M—
93.8K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC FORM 4

Evidence